Cobalt-protoporphyrin improves heart function by blunting oxidative stress and restoring NO synthase equilibrium in an animal model of experimental diabetes

Frontiers in Physiology

Volumn 3 JUN, Issue , 2012, Pages

  Cao, Jian ^a,b   Vecoli, Cecilia ^c,d   Neglia, Danilo ^e   Tavazzi, Barbara ^f   Lazzarino, Giuseppe ^g   Novelli, Michela ^h   Masiello, Pellegrino ^h   Wang, Yu Tang ^a   Puri, Nitin ^b   Paolocci, Nazareno ^d,i   L'Abbate, Antonio ^c,e   Abraham, Nader G ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

^g UNIVERSITY OF CATANIA   (Italy)

^h UNIVERSITY OF PISA   (Italy)

ⁱ UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Ampk; Cardiac contractility; Coronary microcirculation; Diabetes; Nitric oxide

Indexed keywords

EID: 84866347377     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00160     Document Type: Article

References (36)

1. Abraham, N.G., and Kappas, A. (2008). Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev. 60,79-127.
2. Adeghate, E. (2004). Molecular and cellular basis of the aetiology and management of diabetic cardiomy-opathy: a short review. Mol. Cell. Biochem. 261, 187-191.
3. An, D., and Rodrigues, B. (2006). Role of changes in cardiac metabolism in development of diabetic cardiomy-opathy. Am. J. Physiol. Heart Circ. Physiol. 291, H1489-H1506.
4. Antoniades, C., Antonopoulos, A. S., Tousoulis, D., and Stefanadis, C. (2009). Adiponectin: from obesity to cardiovascular disease. Obes. Rev. 10, 269-279.
5. Bardell, A. L., and MacLeod, K. M. (2001). Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats. J. Pharmacol. Exp. Ther. 296, 252-259.
6. Boudina, S., and Abel, E. D. (2007). Diabetic cardiomyopa- thy revisited. Circulation 115, 3213-3223.
7. Boudina, S., and Abel, E. D. (2007). Diabetic cardiomyopa- thy revisited. Circulation 115,3213-3223.
8. Ceriello, A., Quagliaro, L., D'Amico, M., Di Filippo, C., Marfella, R., Nappo, F., Berrino, L., Rossi, F., and Giugliano, D. (2002). Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51, 1076-1082.
9. Chandran, M., Phillips, S. A., Cia-raldi, T., and Henry, R. R. (2003). Adiponectin: more than just another fat cell hormone? Diabetes Care 26, 2442-2450.
10. Di Noia, M. A., Van Driesche, S., Palmieri, F., Yang, L. M., Quan, S., Goodman, A. I., and Abraham, N. G. (2006). Heme oxygenase-1 enhances renal mitochondrial transport carriers and cytochrome C oxidase activity in experimental diabetes. J. Biol. Chem. 281, 15687-15693.
11. Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., and Zeiher, A. M. (1999). Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601-605.
12. Ding, G., Qin, Q., He, N., Francis-David, S. C., Hou, J., Liu, J., Ricks, E., and Yang, Q. (2007). Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upreg-ulated by activation of peroxi-some proliferator-activated receptor gamma. J. Mol. Cell. Cardiol. 43, 73-84.
13. Haidara, M. A., Yassin, H. Z., Rateb, M., Ammar, H., and Zorkani, M. A. (2006). Role of oxidative stress in development of cardiovascular complications in diabetes mel-litus. Curr. Vasc. Pharmacol. 4, 215-227.
14. Hotta, K., Funahashi, T., Arita, Y., Taka-hashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., Nishida, M., Kihara, S., Sakai, N., Naka-jima, T., Hasegawa, K., Muraguchi, M., Ohmoto, Y., Nakamura, T., Yamashita, S., Hanafusa, T., and Mat-suzawa, Y (2000). Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20, 1595-1599.
15. Kim, J. Y., van de, W. E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., Jelicks, L. A., Mehler, M. F., Hui, D. Y., Deshaies, Y., Shulman, G. I., Schwartz, G. J., and Scherer, P. E. (2007). Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117,2621-2637.
16. Koch, M., Wendorf, M., Dendorfer, A., Wolfrum, S., Schulze, K., Spillmann, E, Schultheiss, H. P., and Tschope, C. (2003). Cardiac kinin level in experimental diabetes mellitus: role of kin-inases. Am. J. Physiol. Heart Circ. Physiol. 285, H418-H423.
17. Kusmic, C., L'Abbate, A., Sambuceti, G., Drummond, G., Barsanti, C., Matteucci, M., Cao, J., Piccolomini, F., Cheng, J., and Abraham, N. G. (2010). Improved myocardial per-fusion in chronic diabetic mice by the up-regulation of pLKB1 and AMPK signaling. J. Cell. Biochem. 109, 1033-1044.
18. L'Abbate, A., Neglia, D., Vecoli, C., Novelli, M., Ottaviano, V., Baldi, S., Barsacchi, R., Paolicchi, A., Masiello, P., Drummond, G. S., McClung, J. A., and Abraham, N. G. (2007). Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats. Am. J. Physiol. Heart Circ. Physiol.293, H3532-H3541.
19. Lazzarino, G., Amorini, A. M., Fazz-ina, G., Vagnozzi, R., Signoretti, S., Donzelli, S., Di Stasio, E., Giardina, B., and Tavazzi, B. (2003). Single-sample preparation for simultaneous cellular redox and energy state determination. Anal. Biochem. 322, 51-59.
20. LeWinter, M. M. (1996). Diabetic car-diomyopathy: an overview. Coron. Artery Dis. 7,95-98.
21. Li, M., Kim, D. H., Tsenovoy, P. L., Peterson, S. J., Rezzani, R., Rodella, L. F., Aronow, W. S., Ikehara, S., and Abraham, N. G. (2008). Treatment of obese diabetic mice with a heme oxy-genase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 57,1526-1535.
22. Lopaschuk, G. D. (1996). Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrate/lipid metabolism. Coron. Artery Dis. 7, 116-123.
23. Nagareddy, P. R., Xia, Z., McNeill, J. H., and MacLeod, K. M. (2005). Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am. J. Physiol. Heart Circ. Physiol. 289, H2144-H2152.
24. Ouchi, N., Kobayashi, H., Kihara, S., Kumada, M., Sato, K., Inoue, T., Funahashi, T., and Walsh, K. (2004). Adiponectin stimulates angiogenesis by promoting crosstalk between AMP-activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem. 279, 1304-1309.
25. Pacher, P., Liaudet, L., Bai, P., Mab-ley, J. G., Kaminski, P. M., Virag, L., Deb, A., Szabo, E., Ungvari, Z., Wolin, M. S., Groves, J. T., and Szabo, C. (2003).Potent metallopor-phyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107, 896-904.
26. Park, H., Kaushik, V. K., Constant, S., Prentki, M., Przybytkowski, E., Ruderman, N. B., and Saha, A. K. (2002). Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltrans-ferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J. Biol. Chem. 277, 32571-32577.
27. Ruderman, N. B., Saha, A. K., Vavvas, D., and Witters, L. A. (1999). Malonyl-CoA, fuel sensing, and insulin resistance. Am. J. Physiol. 276, E1-E18.
28. Sharma, S., Adrogue, J. V., Golfman, L., Uray, I., Lemm, J., Youker, K., Noon, G. P., Frazier, O. H., and Taegt-meyer, H. (2004). Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEBJ. 18,1692-1700.
29. Stefan, N., Vozarova, B., Funahashi, T., Matsuzawa, Y., Weyer, C., Lindsay, R. S., Youngren, J. F., Havel, P. J., Pratley, R. E., Bogardus, C., and Tataranni, P. A. (2004). Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 18, 1692-1700.
30. Stevens, M. J. (2005). Oxidative-nitrosative stress as a contributing factor to cardiovascular disease in subjects with diabetes. Curr. Vasc. Pharmacol. 3, 253-266.
31. Szabo, C., Mabley, J. G., Moeller, S. M., Shimanovich, R., Pacher, P., Virag, L., Soriano, E G., Van Duzer, J. H., Williams, W., Salzman, A. L., and Groves, J. T. (2002). Part I: patho-genetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol. Med. 8, 571-580.
32. Tao, L., Gao, E., Jiao, X., Yuan, Y., Li, S., Christopher, T. A., Lopez, B. L., Koch, W., Chan, L., Goldstein, B. J., and Ma, X. L. (2007). Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115, 1408-1416.
33. Turkseven, S., Kruger, A., Mingone, C. J., Kaminski, P., Inaba, M., Rodella, L. F., Ikehara, S., Wolin, M. S., and Abraham, N. G. (2005). Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am. J. Physiol. Heart Circ. Physiol. 289, H701-H707.
34. Weinstein, D. M., Mihm, M. J., and Bauer, J. A. (2000). Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J. Pharmacol. Exp. Ther. 294, 396-401.
35. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., and Tataranni, P. A. (2001). Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperin-sulinemia. J. Clin. Endocrinol. Metab. 86, 1930-1935.
36. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M. L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P., and Kad-owaki, T. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941-946.